Free Design Audit Available - Click Here for Details

CardioPrecision makes “global breakthrough” in robot-assisted heart surgery

A Glasgow-based company has played a leading role in bringing the “world’s first” aortic valve replacement through a tiny incision in the neck closer to reality.

CardioPrecision, a specialist in less invasive treatment of structural heart disease, recently demonstrated a proof-of-concept Advanced Videoscopic Aortic valve surgery by Transcervical Approach using Robot-assistance (AVATAR) procedure in Chicago, Illinois, USA.

The procedure was successfully performed on a series of human cadavers, representing an important milestone in progressing towards clinical cases while also continuing to grow CardioPrecision’s Stateside presence.

The company, originally spun out of the NHS through InnoScot Health – utilised its CoreVista Robot Enabling Platform, as well as the Perceval Plus sutureless aortic valve from UK-based Corcym, a global medical device company focused on the structural heart area.

CardioPrecision’s chief medical officer and consultant cardiothoracic surgeon, Fraser Sutherland, worked closely with Rocco Bilancia, consultant thoracic surgeon at Scotland’s Golden Jubilee University National Hospital, to introduce AVATAR to leading US robotic surgeons, Professor Husam Balkhy from the University of Chicago Medicine and Professor Danny Ramzy at Memorial Hermann of University of Texas Houston.

Sign up for Blog Updates